0.00Open0.00Pre Close0 Volume0 Open Interest1.00Strike Price0.00Turnover824.81%IV79.08%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.0194Delta0.0099Gamma95.60Leverage Ratio-0.0196Theta0.0000Rho-1.85Eff Leverage0.0003Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet